LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Barasertib | 1.11 | uM | LJP5 | 1 | D09 | 72 | hr | 1694 | 1879 | 11042 | 0.1702 | 0.0390 |
MCF 10A | Barasertib | 1.11 | uM | LJP5 | 2 | D09 | 72 | hr | 1694 | 2025 | 11099 | 0.1824 | 0.0680 |
MCF 10A | Barasertib | 1.11 | uM | LJP5 | 3 | D09 | 72 | hr | 1694 | 2077 | 11168 | 0.1860 | 0.0777 |
MCF 10A | Barasertib | 3.33 | uM | LJP5 | 1 | D08 | 72 | hr | 1694 | 1986 | 11042 | 0.1799 | 0.0605 |
MCF 10A | Barasertib | 3.33 | uM | LJP5 | 2 | D08 | 72 | hr | 1694 | 2173 | 11099 | 0.1958 | 0.0961 |
MCF 10A | Barasertib | 3.33 | uM | LJP5 | 3 | D08 | 72 | hr | 1694 | 2113 | 11168 | 0.1892 | 0.0846 |
MCF 10A | Barasertib | 10 | uM | LJP5 | 1 | D07 | 72 | hr | 1694 | 2080 | 11042 | 0.1884 | 0.0788 |
MCF 10A | Barasertib | 10 | uM | LJP5 | 2 | D07 | 72 | hr | 1694 | 1971 | 11099 | 0.1776 | 0.0574 |
MCF 10A | Barasertib | 10 | uM | LJP5 | 3 | D07 | 72 | hr | 1694 | 2098 | 11168 | 0.1879 | 0.0817 |
MCF 10A | Vemurafenib | 0.04 | uM | LJP5 | 1 | C18 | 72 | hr | 1694 | 10731 | 11042 | 0.9718 | 0.9790 |
MCF 10A | Vemurafenib | 0.04 | uM | LJP5 | 2 | C18 | 72 | hr | 1694 | 11286 | 11099 | 1.0168 | 1.0123 |
MCF 10A | Vemurafenib | 0.04 | uM | LJP5 | 3 | C18 | 72 | hr | 1694 | 10873 | 11168 | 0.9736 | 0.9804 |
MCF 10A | Vemurafenib | 0.12 | uM | LJP5 | 1 | C17 | 72 | hr | 1694 | 10605 | 11042 | 0.9604 | 0.9703 |
MCF 10A | Vemurafenib | 0.12 | uM | LJP5 | 2 | C17 | 72 | hr | 1694 | 11177 | 11099 | 1.0070 | 1.0051 |
MCF 10A | Vemurafenib | 0.12 | uM | LJP5 | 3 | C17 | 72 | hr | 1694 | 10790 | 11168 | 0.9661 | 0.9748 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 1 | C16 | 72 | hr | 1694 | 10839 | 11042 | 0.9816 | 0.9863 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 2 | C16 | 72 | hr | 1694 | 11162 | 11099 | 1.0056 | 1.0041 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 3 | C16 | 72 | hr | 1694 | 10917 | 11168 | 0.9775 | 0.9833 |
MCF 10A | Vemurafenib | 1.11 | uM | LJP5 | 1 | C15 | 72 | hr | 1694 | 10636 | 11042 | 0.9632 | 0.9725 |
MCF 10A | Vemurafenib | 1.11 | uM | LJP5 | 2 | C15 | 72 | hr | 1694 | 11085 | 11099 | 0.9987 | 0.9990 |
MCF 10A | Vemurafenib | 1.11 | uM | LJP5 | 3 | C15 | 72 | hr | 1694 | 10891 | 11168 | 0.9752 | 0.9816 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 1 | C14 | 72 | hr | 1694 | 9040 | 11042 | 0.8187 | 0.8574 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 2 | C14 | 72 | hr | 1694 | 9507 | 11099 | 0.8565 | 0.8890 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 3 | C14 | 72 | hr | 1694 | 8778 | 11168 | 0.7860 | 0.8306 |
MCF 10A | Vemurafenib | 10 | uM | LJP5 | 1 | C13 | 72 | hr | 1694 | 4983 | 11042 | 0.4513 | 0.4902 |